Multiple Sclerosis (MS)
Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system characterised by inflammation, demyelination, and neurodegeneration. It affects the brain, spinal cord, and optic nerves, producing a wide range of neurological symptoms that often follow a relapsing or progressive course. Unlike peripheral demyelinating disorders, multiple sclerosis disrupts communication within the central nervous system itself. MS presents across acute, outpatient, and community settings, often in younger adults. Understanding the pathophysiology helps explain fluctuating symptoms, unpredictable disease patterns, and the cumulative impact of neurological damage over time.
What You Need to Know
Multiple sclerosis is an immune-mediated disorder of the central nervous system in which inflammation targets myelin, the insulating layer that surrounds axons and enables rapid electrical conduction. When myelin is damaged, nerve impulses slow or fail to propagate, disrupting communication between the brain, spinal cord, and the structures they control. This interruption produces neurological symptoms that vary depending on the location and extent of inflammatory lesions.
Inflammation in multiple sclerosis does not affect myelin alone. Oligodendrocytes, the cells responsible for producing and maintaining myelin, are also injured, and axons themselves may be damaged during inflammatory episodes. These combined effects lead to transient or persistent neurological dysfunction, with symptom patterns shaped by which neural pathways are involved at a given time.
At a broad level, multiple sclerosis involves several interacting processes:
Immune-driven inflammation causing focal areas of demyelination within the central nervous system
Disruption of electrical conduction along affected axons, leading to neurological symptoms
Variable capacity for remyelination and recovery early in the disease
In the early stages, remyelination can occur, allowing partial or complete recovery of function after an inflammatory episode. With repeated attacks, repair becomes less effective, and cumulative axonal injury develops. Over time, this results in permanent neurological deficits and progressive disability, reflecting the transition from predominantly inflammatory injury to irreversible structural damage within the central nervous system.
Beyond the Basics
Central demyelination and conduction failure
Within the central nervous system, myelin is critical for fast and reliable signal transmission along long neural pathways. Myelin enables saltatory conduction, where electrical impulses jump between nodes along the axon rather than travelling continuously. In multiple sclerosis, inflammatory demyelination disrupts this process, causing signals to slow, become distorted, or fail to propagate altogether.
When conduction becomes unreliable, communication between brain regions, the spinal cord, and peripheral targets is impaired. This produces neurological deficits that vary widely depending on lesion location. For example, demyelination affecting optic pathways alters visual input, while involvement of spinal tracts interferes with motor or sensory transmission. The patchy distribution of lesions explains why symptoms can appear scattered, fluctuate over time, and differ markedly between individuals.
Inflammation, axonal injury, and disease progression
Inflammation is the dominant driver of early multiple sclerosis activity, but it is not the only source of long-term damage. During inflammatory episodes, axons may be directly injured by immune-mediated mechanisms or secondarily damaged by loss of myelin support. Axonal injury limits the ability of affected pathways to recover fully, even if inflammation later resolves.
As axonal damage accumulates, neural networks lose redundancy and functional reserve. This reduces the capacity for compensation and contributes to more persistent deficits. Over time, neurological decline becomes less closely linked to acute inflammation and more related to irreversible structural injury within the central nervous system, which explains reduced responsiveness to anti-inflammatory therapies in later disease stages.
Relapsing and progressive disease patterns
The clinical course of multiple sclerosis aligns with these underlying mechanisms. Relapses occur during periods of active inflammation, when new demyelinating lesions disrupt neural signalling and produce acute symptoms. As inflammation subsides, remyelination and neural adaptation allow partial or complete symptom improvement.
Progressive disease emerges as cumulative axonal loss and incomplete repair reduce overall neural capacity. In this phase, neurological function gradually worsens even in the absence of overt inflammatory attacks. Decline occurs because remaining pathways can no longer compensate for ongoing structural loss, leading to steady progression rather than discrete relapses.
Clinical Connections
Symptoms of multiple sclerosis vary widely and may include visual disturbance, sensory change, limb weakness, impaired coordination, fatigue, and cognitive dysfunction. Presentation depends on the location and extent of demyelinating lesions within the central nervous system, which means symptoms can appear unrelated or fluctuate over time. Involvement of optic pathways alters vision, spinal cord lesions affect motor and sensory function, and cerebral involvement contributes to cognitive and emotional change.
Clinical patterns are shaped by lesion distribution and ongoing axonal injury:
Fluctuating or episodic symptoms during periods of inflammatory activity
Partial recovery as inflammation settles and conduction improves
Gradual accumulation of persistent deficits as axonal loss progresses
Changes in symptoms are often influenced by physiological stressors. Infection, emotional stress, and increased body temperature can worsen neurological function by further impairing conduction along demyelinated axons, a phenomenon commonly experienced as transient symptom worsening. This occurs because damaged myelin reduces the safety margin for electrical transmission, making neural signalling more vulnerable to metabolic and thermal stress.
Ongoing assessment focuses on identifying new or evolving neurological change, distinguishing relapse from transient exacerbation, and recognising gradual progression. Appreciating the underlying demyelination and axonal injury provides context for symptom variability and supports timely escalation when changes fall outside an individual’s established pattern.
Concept Check
How does central demyelination differ from peripheral demyelination at a functional level?
Why can symptoms partially resolve after an MS relapse?
How does axonal injury contribute to long-term disability in multiple sclerosis?
Why do MS symptoms vary so widely between individuals?
How does understanding MS pathophysiology support nursing assessment and patient education?